Combining talazoparib with enzalutamide significantly improves overall survival in patients with metastatic castration-resistant prostate cancer compared with enzalutamide alone.

For me this only prolongs the agony, defeat at Motherwell and a hiding from Celtic and Gray is gone. John: A timely performance but scoring three goals to get a draw underlines our defensive ...

Michigan Medicine researchers have developed a SCN1B gene therapy that restores brain function and survival in mice with ...